Cannabis Law Report

JANUARY 11, 2019

Accordingly, the Drug Enforcement Administration (DEA) no longer has any claim to interfere with the interstate commerce of hemp products, so as long as the THC level is at or below 0.3%. While the DEA is now officially out of the hemp regulation business, the U.S. The FDA’s position on CBD is unsettled and unsupported by law.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

The Cannigma

JULY 3, 2023

They found that it could be used in sessions to promote trust and safety, helping patients to open up and process traumatic experiences. Sometimes insufflated Inhalation, oral, topical, sublingual and transdermal Other names E, X, Ecstasy, Molly, XTC, The Love Drug Weed, marijuana, pot, ganja, dope, grass… the list goes on.

Research and Development 46

Research and Development Environment THC Microdosing 46

Cannabis Law Report

JUNE 1, 2021

33%. – Beverages, edibles, topicals. and vapes. 14%. – Beverages, edibles, topicals. and vapes. Drug Enforcement Administration (the “DEA”), the U.S. Canadian recreational cannabis. – Dry bud[8]. – – Oils and softgels8. 73%. – Excise taxes.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

AUGUST 6, 2021

Beverages, edibles, topicals 7. and vapes. Beverages, edibles, topicals. and vapes. Drug Enforcement Administration (the “DEA”), the U.S. Other revenue adjustments 8. $(3.0). Excise taxes. Medical cannabis and other. – Oils and softgels. Excise taxes. $(1.4). state and federal law to U.S.

Vaping 105

Vaping Research and Development Data Business 105

Cannabis Law Report

SEPTEMBER 23, 2019

Therefore, the AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the effects of those laws on patient and societal health. The AAFP supports requirements testing current marijuana and cannabinoid products for safety, dosing, and product consistency. In the Exam Room.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

JULY 14, 2021

Cannabis banking has been a tricky topic to tackle in recent years. Drug Enforcement Agency (DEA) to the Alcohol and Tobacco Tax and Trade Bureau (TTB), the Bureau of Alcohol Tobacco Firearms and Explosives (ATF), as well as the Food and Drug Administration (FDA) to protect public health. Ganjapreneur. Marijuana Times.

Legislation 71

Legislation Banking History Access 71

Canna Law Blog

SEPTEMBER 6, 2023

Many people in the cannabis industry are convinced that this HHS recommendation to the Drug Enforcement Administration (DEA) means that the DEA will undertake this rescheduling (and fairly quickly, too–which would be a huge departure from its refusal to reschedule back in 2016). Just my two cents; feel free to disagree.

Research and Development 126

Research and Development DEA Marijuana Pharmaceutical 126

Project CBD

AUGUST 23, 2023

8 Safety Issues Associated with Synthetic Cannabinoids This new generation of designer drugs is reminiscent of “Spice,” “K2,” and other synthetic cannabinoids that emerged in the illicit drug market in the early 2000s. 9 We cannot assume that these novel compounds are safe based on the safety profile of natural cannabinoids. .”

Cannabinoids 142

Cannabinoids Hemp THC Safety 142

Meadow

JULY 13, 2018

The panel covered a wide range of topics local regulators are currently dealing with, including reconciling local and state regulations, enforcement of illicit businesses, license caps, equity and diversity, delivery, onsite consumption, and, of course, taxes. I think over the long term, taxes are going to remain a very important topic.

Wellness and Beauty 40

Wellness and Beauty Policy Consumption Cannabis 40

Canna Law Blog

NOVEMBER 16, 2021

The enforcement role moves from DEA to ATF. When it comes to enforcing federal cannabis regulations, the Drug Enforcement Administration (“DEA”) is out and the Bureau of Alcohol, Tobacco, Firearms, and Explosives (“ATF”) is in (in addition to TTB as the primary overseer). Age limits (21). ” SBA fairness.

DEA 98

DEA Business Banking Food 98

Cannabis Law Report

MAY 29, 2022

Celebrated author Michael Pollan has published two bestselling books on the topic: How to Change Your Mind and This is Your Mind on Plants. 8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. DEA and the Controlled Substances Act. Times (Nov. 11, 2021), [link]. [10]

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

NOVEMBER 2, 2021

Testing for Safety: Are Impurities a Problem? Testing for Safety: Are Impurities a Problem? Based on our analysis, there are currently around 160 companies selling delta-8 THC products online, with more than 4,200 unique products for sale, including edibles, concentrates, vapes, flower, prerolls, tinctures, topicals and beverages.

THC 96

THC CBD Legalization Vaping 96

Veriheal

DECEMBER 1, 2022

On October 30, during a friendly as-can-be debate with Senate Majority Leader Chuck Schumer and Republican challenger Joseph Pinion, the SAFE Banking Act was the topic of discussion. This also would ensure that federal regulation protects public health and safety and prioritize restorative and economic justice.

Access 111

Access Banking Policy Legislation 111

SpeedWeed

APRIL 1, 2021

As federal and state governments tackle the legalization of hemp as a distinct product from cannabis, the safety of the products produced from hemp isn’t getting the same attention as those produced from THC-based cannabis. Testing failures highlight the need for national regulations on hemp.

THC 52

THC Hemp CBD Vaping 52

CannaMD

SEPTEMBER 10, 2020

This creates a somewhat confusing landscape for mothers who might benefit from cannabis-based therapies, but are also concerned for the safety of their child and the very real possibility of institutional intervention when marijuana use during pregnancy is documented. But despite these revelations, both messaging and legalities have lagged.

Marijuana 88

Marijuana Therapy Data THC 88

Cannabis Law Report

DECEMBER 1, 2019

1595 [the Secure And Fair Enforcement (SAFE) Banking Act of 2019] was introduced to increase public safety by expanding financial services to marijuana-related legitimate businesses and service providers and reducing the amount of cash at such businesses. None of these bills has been passed by Congress so far. State Board Positions.

Marijuana 59

Marijuana Business State Laws DEA 59

SpeedWeed

MARCH 18, 2021

Given the topical nature of the current trial and its relevance for public policy on medical cannabis, participants might have been biased to report positive effects regardless of condition. Wasn’t the DEA going to let others grow research-grade cannabis? It tested at only 9% THC. Bruce Kennedy.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

The Cannigma

SEPTEMBER 12, 2021

The safety of using these products however, is still unknown. Marijuana (defined in the US as any cannabis plant where THC>0.3%) is a schedule I drug according to the DEA and FDA. Products infused with isolated THC mostly include oils, edibles and topicals. Who discovered THC? Consumption methods.

THC 98

THC Research and Development Cannabinoids CBD 98

Cannabis Law Report

FEBRUARY 28, 2022

Show More According to the Drug Enforcement Administration (DEA), Schedule I drugs have “no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse.” In 2017, the FDA designated MDMA a breakthrough therapy for PTSD. Feduccia et al., 19 × 19.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Veriheal

FEBRUARY 1, 2021

The filing is backed by MAPS (Multidisciplinary Association for Psychedelic Studies) and calls on the DEA to answer a four-year-old filing requesting approval of his application to become a federally registered marijuana cultivator. Back in 2016, the DEA said they were starting the process of approving “additional marijuana cultivators.”

DEA 76

DEA Therapy Cultivation Media 76

Canna Law Blog

SEPTEMBER 4, 2024

Earlier this year, the DEA initiated rulemaking to reclassify cannabis as a schedule III narcotic. Those hopes were dashed when the DEA scheduled a hearing for the proposed reclassification about a month after the election. My colleague, Vince Sliwoski, wrote a post on DEA’s hearing announcement here.

DEA 103

DEA Cannabis Legislation Topical 103